Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

Share Price Information for Amati Aim Vct (AMAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 85.50
Bid: 85.00
Ask: 86.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.176%)
Open: 85.50
High: 85.50
Low: 85.50
Prev. Close: 85.50
AMAT Live PriceLast checked at -
Amati AIM VCT is an Investment Trust

To generate tax free capital gains and regular dividend income, invests primarily in AIM-traded companies and non-qualifying investments as allowed by the VCT legislation.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Offer for subscription

1 Feb 2019 07:00

RNS Number : 7190O
Amati AIM VCT PLC
01 February 2019
 

1 February 2019

 

 

Amati AIM VCT plc (the "Company")

Legal Entity Identifier: 213800HAEDBBK9RWCD25

 

Offer for Subscription

The Directors of Amati AIM VCT plc are pleased to announce that the Company has today published a top up offer document (the "Information Document") in connection with proposals to raise up to approximately £7 million, by way of offers for subscription of new ordinary shares (the "Offer").

The Offer, which is being managed under the limits applicable to non-prospectus rules, opens on Friday 1 February 2019 and is expected to close at noon on Thursday 4 April 2019 in respect of the 2018/2019 tax year and at noon on Friday 12 July 2019 in respect of the 2019/2020 tax year (or on an earlier date if the maximum subscription is received). While applications are invited from both existing shareholders and new investors, existing shareholders will be given priority to subscribe until 18 February 2019. Once demand from existing shareholders who have applied during this initial period is satisfied, all further applications will be processed on a first come, first served basis, subject to the discretion of the directors. The directors may, at their discretion, close the Offer earlier than indicated or decide to extend the Offer.

The Offer is being managed such that existing shareholders submitting applications received on or before 18 February 2019 will receive their full requested allocation insofar as the capacity of the Offer allows. Should the offer be fully or over-subscribed during this initial period, existing shareholders will be guaranteed their pre-emption entitlement, which will be determined in proportion to the number of shares held.

Further, existing shareholders applying during the initial period will not be subject to the minimum subscription requirement per investor of £4,000 per tax year, so it is therefore not necessary to make a distinction between shares applied for under pre-emption rights and those applied for under the general Offer. Should existing shareholders decide to apply within the initial period of the Offer in order to secure their pre-emption entitlement, they should apply in the normal way, for the total monetary amount for which they wish to subscribe, and the Company will contact applicants in the event that a scaling back of allocations becomes necessary (subject to the minimum entitlement).

The new ordinary shares will be issued at a price determined in accordance with a formula to allow for issue costs (as set out in the Offer Document) and based on the last published net asset value per share ("NAV per Share") of the Company prior to the date of issue. The NAV per Share will be divided by 0.99 to determine the issue price for applications from existing shareholders and shares issued in respect of applications received through authorised financial intermediaries, which allows for issue costs of 1%. For all other applications the NAV per Share will be divided by 0.97 to determine the issue price, which allows for issue costs of 3%. Upon issue, the new ordinary shares will be admitted to the Official List of the UKLA and to trading on the Main Market of the London Stock Exchange.

The Information Document and the covering circular to shareholders (the "Letter") with details of the pre-emption offer are available to download at www.amatiglobal.com or you can contact Amati Global Investors by phone on 0131 503 9115 or by email at info@amatiglobal.com to request hard copies. These documents will also be submitted to the National Storage Mechanism for viewing online at www.morningstar.co.uk/uk/NSM.

For further information please contact Samantha Dalby on 0131 503 9115 or email info@amatiglobal.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRBBMJTMBAJBIL
Date   Source Headline
2nd May 202410:38 amRNSNet Asset Value(s)
1st May 20243:59 pmRNSTotal Voting Rights
30th Apr 20245:03 pmRNSTransaction in Own Shares
26th Apr 20244:29 pmRNSNet Asset Value(s)
22nd Apr 202411:21 amRNSNet Asset Value(s)
15th Apr 202410:36 amRNSNet Asset Value(s)
12th Apr 20247:00 amRNSAnnual Financial Report
8th Apr 202411:58 amRNSNet Asset Value(s)
3rd Apr 20241:04 pmRNSNet Asset Value(s)
3rd Apr 202412:15 pmRNSTransaction in Own Shares
2nd Apr 202411:06 amRNSTotal Voting Rights
25th Mar 20242:26 pmRNSTransaction in Own Shares
25th Mar 202412:39 pmRNSNet Asset Value(s)
18th Mar 20241:55 pmRNSNet Asset Value(s)
15th Mar 20243:00 pmRNSTransaction in Own Shares
14th Mar 20245:11 pmRNSCompliance with Market Abuse Regulation
14th Mar 20247:00 amRNSStrategic Review
11th Mar 202410:12 amRNSNet Asset Value(s)
4th Mar 20249:55 amRNSNet Asset Value(s)
1st Mar 20244:18 pmRNSTotal Voting Rights
29th Feb 20242:27 pmRNSTransaction in Own Shares
26th Feb 202410:03 amRNSNet Asset Value(s)
19th Feb 202410:21 amRNSNet Asset Value(s)
14th Feb 20244:36 pmRNSTransaction in Own Shares
9th Feb 20244:56 pmRNSNet Asset Value(s)
2nd Feb 20246:03 pmRNSTransaction in Own Shares
2nd Feb 202412:15 pmRNSNet Asset Value(s)
1st Feb 20242:21 pmRNSTotal Voting Rights
29th Jan 202411:53 amRNSNet Asset Value(s)
26th Jan 20245:14 pmRNSTransaction in Own Shares
19th Jan 20245:03 pmRNSNet Asset Value(s)
16th Jan 20244:34 pmRNSTransaction in Own Shares
15th Jan 20244:20 pmRNSDirector/PDMR Shareholding
15th Jan 20247:00 amRNSIssue of Equity
12th Jan 20242:51 pmRNSNet Asset Value(s)
5th Jan 20245:29 pmRNSNet Asset Value(s)
3rd Jan 202412:44 pmRNSNet Asset Value(s)
2nd Jan 20241:58 pmRNSTotal Voting Rights
21st Dec 20233:45 pmRNSNet Asset Value(s)
20th Dec 20233:56 pmRNSTransaction in Own Shares
18th Dec 20237:00 amRNSNet Asset Value(s)
11th Dec 202311:01 amRNSNet Asset Value(s)
4th Dec 202310:44 amRNSNet Asset Value(s)
1st Dec 202310:25 amRNSTotal Voting Rights
30th Nov 20234:02 pmRNSDividend Declaration
28th Nov 202312:46 pmRNSTransaction in Own Shares
27th Nov 202312:16 pmRNSDirector/PDMR Shareholding
27th Nov 20239:34 amRNSIssue of Equity
24th Nov 20234:23 pmRNSNet Asset Value(s)
20th Nov 202310:19 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.